MINDCURE Files Provisional Patent Application For iSTRYM, its Digital Therapeutics (DTx) SaaS Platform Mar 31, 2021
MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board Mar 29, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Mar 24, 2021
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin Mar 23, 2021
